Growth Metrics

Intelligent Bio Solutions (INBS) Cash from Operations (2020 - 2024)

Intelligent Bio Solutions has reported Cash from Operations over the past 5 years, most recently at 2446564.0 for Q1 2024.

  • Quarterly results put Cash from Operations at 2446564.0 for Q1 2024, up 2.85% from a year ago — trailing twelve months through Mar 2024 was 7211893.0 (up 15.32% YoY), and the annual figure for FY2023 was 7377378.0, down 119.69%.
  • Cash from Operations for Q1 2024 was 2446564.0 at Intelligent Bio Solutions, up from 2869158.0 in the prior quarter.
  • Over the last five years, Cash from Operations for INBS hit a ceiling of 194975.0 in Q2 2020 and a floor of 6159435.0 in Q1 2021.
  • Median Cash from Operations over the past 5 years was 1682811.0 (2021), compared with a mean of 1687242.35.
  • Peak annual rise in Cash from Operations hit 103.1% in 2021, while the deepest fall reached 2717.02% in 2021.
  • Intelligent Bio Solutions' Cash from Operations stood at 776967.0 in 2020, then tumbled by 83.48% to 1425567.0 in 2021, then tumbled by 67.01% to 2380850.0 in 2022, then dropped by 20.51% to 2869158.0 in 2023, then rose by 14.73% to 2446564.0 in 2024.
  • The last three reported values for Cash from Operations were 2446564.0 (Q1 2024), 2869158.0 (Q4 2023), and 1311833.0 (Q3 2023) per Business Quant data.